PRL and neurofibromatosis type 1: Our data underline the need for the early recognition and investigation for gigantism or acromegaly in patients with NF1, including a careful and thorough investigation of the pituitary gland through imaging using techniques for three dimensional volumetric measurements [54], and serial overnight GH and prolactin measurements, if feasible.